By BISHAL GYAWALI, MD Why conduct post approval studies at all? Atezolizumab previously received accelerated approval in second-line metastatic or advanced urothelial cancer based on response rates from a single arm trial. The results of post approval
Read More...
Read the complete post at http://thehealthcareblog.com/blog/2018/02/07/the-optimistic-oncologist/
Posted
Feb 07 2018, 09:09 AM
by
THCB